A single dose of liposome-encapsulated hydromorphone provides extended analgesia in a rat model of neuropathic pain

Comparative Medicine

Volumn 56, Issue 6, 2006, Pages 487-492

  Smith, Lesley J ^a   Valenzuela, Janice R ^a   Krugner Higby, Lisa A ^b   Brown, Carolyn ^b   Heath, Timothy D ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROMORPHONE; LIPOSOME; PHOSPHATIDYLCHOLINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENCAPSULATION; HYPERALGESIA; LATENT PERIOD; MALE; NEUROPATHIC PAIN; NONHUMAN; RAT; RODENT; SCIATIC NERVE; STANDARD; THERMAL INJURY; WITHDRAWAL REFLEX;

ANALGESICS, OPIOID; ANIMALS; DELAYED-ACTION PREPARATIONS; DISEASE MODELS, ANIMAL; HYDROMORPHONE; HYPERALGESIA; LIPOSOMES; MALE; NEURALGIA; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 33845633886     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Abram SE, Mampilly GA, Milosavlj evic D. 1997. Assessment of the potency and intrinsic activity of systemic versus intrathecal opioids in rats. Anesthesiology 87:127-134.
2. Backonja M-M, Miletic G, Miletic V. 1995. The effect of continuous morphine analgesia on chronic thermal hyperalgesia due to sciatic constriction injury in rats. Neurosci Lett. 196:61-64.
3. Bennett GJ, Xie YK. 1988. Aperipheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87-107.
4. Bernards CM, Luger JT, Malmberg AK, Hill HF, Yaksh TL. 1992. Liposome encapsulation prolongs alfentanil spinal analgesia and alters systemic redistribution in the rat. Anesthesiology 77:529-535.
5. Carter GJ, Galer BS. 2001. Advances in the management of neuropathic pain. Phys Med Rehabil Clin N Am 12(2):447-459.
6. Chaplan SR, Calcutt NA, Yaksh TL. 1995. Pharmacology of tactile allodynia in the streptozotocin diabetic rat. Soc Neurosci Abstr 21:1172.
7. Clark MD, Krugner-Higby L, Smith LJ, Heath TD, Clark KL, Olson D. 2004. Evaluation of liposome-encapsulated (LE) oxymorphone hydrochloride in mice after splenectomy. Comp Med 54(5):518-523.
8. Desmeules JA, Kayser V, Guilbaud G. 1993. Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain. Pain 53:277-285.
9. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. 1988. Anew and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88.
10. Hasirci V, Bonney I, Goudas LC, Shuster L, Carr DB, Wise DL. 2003. Antihyperalgesic effect of simultaneously released hydromorphone and bupivicaine from polymer fibers in the rat chronic constriction injury model. Life Sci 73:3323-3337.
11. Hawk CT, Leary SL. 1999. Formulary for laboratory animals, 2nd ed. Ames (IA): Iowa State University Press, p 19.
12. Heath TD. 2004. Personal communcation.
13. Howell SB. 2001. Clinical applications of a novel sustained release injectable drug delivery system: Depofoam technology. Cancer J 7:219-222.
14. Kim T, Kim J, Kim S. 1993. Extended-release formulation of morphine for subcutaneous administration. Cancer Chemother Pharmacol 33:187-190.
15. Kim T, Murdande S, Gruber A, Kim S. 1996. Sustained release morphine for epidural analgesia in rats. Anesthesiology 85(2):1-15.
16. Kirby CJ, Gregoriadis G. 1984. A simple procedure for preparing liposomes capable of high encapsulation efficiency under mild conditions. In: Gregoriadis G, editor. Liposome technology, vol 1. Boca Raton (FL): CRC Press, p 19-27.
17. Krugner-Higby L, Smith LJ, Clark M, Heath TD, Dahly E, Schiffman B, Hubbard-VanStelle S, Ney D, Wendland A. 2003. Liposome-encapsulated oxymorphone hydrochloride provides prolonged relief of post-surgical visceral pain in rats. Comp Med 53(3):270-279.
18. McCleane G. 2003. Pharmacologic management of neuropathic pain. CNS Drugs 17(14):1031-1043.
19. Neter J, Wasserman W, Kutner MH. 1990. Analysis of factor level effects. In: Neter J, Wasserman W, Kutner MH. editors. Applied linear statistical models, vol 3. Boston: Irwin, p 585-592.
20. Pascoe PJ. 2000. Opioid analgesics. Vet Clin N Am Small Anim Pract 30(4):757-772.
21. Pettifer G, Dyson D. 2000. Hydromorphone: a cost-effective alternative to the use of oxymorphone. Can Vet J 41(2):135-137.
22. Quigley C, Wiffen P. 2003. A systematic review of hydromorphone in acute and chronic pain. J Pain Sympt Manag 25(2):169-178.
23. Robinson EP, Faggella AM, Henry DP, Russell WL. 1988. Comparison of histamine release induced by morphine and oxymorphone administration in dogs. Am J Vet Res 49:1699-1701.
24. Rose JS, Neal JM, Kopacz DJ. 2005. Extended-duration analgesia: update on microspheres and liposomes. Reg Anesth Pain Med 30(3):275-285.
25. Sarhill N, Walsh D, Nelson KA. 2001. Hydromorphone: pharmacology and clinical applications in cancer patients. Support Care Cancer 9:84-96.
26. Smith LJ, Krugner-Higby L, Heath TD. 2006. Unpublished data.
27. Smith LJ, Krugner-Higby L, Heath TD, Clark M. 2003. A single dose of liposome-encapsulated oxymorphone or morphine provides long-term analgesia in an animal model of neuropathic pain. Comp Med 53(3):280-287.
28. Smith LJ, Yu K-A J, Bjorling DE, Waller K. 2001. Effects of hydromorphone or oxymorphone, with or without acepromazine, on preanesthetic sedation, physiologic values, and histamine release in dogs. J Am Vet Med Assoc 218(7):1101-1105.
29. Tejwani GA, Rattan AK. 2002. The role of spinal opioid receptors in the antinociceptive effects produced by intrathecal administration of hydromorphone and buprenorphine in the rat. Anesth Analg 94:1542-1546.
30. Viscusi ER. 2005. Translational vignette: liposomal drug delivery for postoperative pain management. Reg Anesth Pain Med 30(5):49-496.
31. Wallace MS. 2001. Pharmacologic treatment of neuropathic pain. Current Pain Headache Rep 5:138-150.
32. Watson CPN, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. 2003. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 105:71-78.
33. Woolf CJ, Mannion RJ. 1999. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353:1959-1964.
34. Yaksh TL, Provencher JC, Rathbun ML, Kohn FR. 1999. Pharma-cokinetics and efficacy of epidurally delivered sustained release encapsulated morphine in dogs. Anesthesiology 90(5):102-112.
35. Yaksh TL, Provencher JC, Rathbun ML, Myers RR, Powell H, Richter P, Kohn FR. 2000. Encapsulated morphine delivered epidurally in a sustained-release multivescicular liposome in dogs. Drug Deliv 7:1-10.
36. Yamamoto T, Yaksh TL. 1991. Spinal pharmacology of thermal hyperesthesia induced by incomplete ligation of sciatic nerve. I. Opioid and nonopioid receptors. Anesthesiology 75:817-826.
37. Yeomans DC, Cooper BY, Vierck CJ. 1996. Effects of systemic morphine on responses of primates to first or second pain sensations. Pain 66:253-263.
38. Yeomans DC, Proudfit HK. 1996. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: electrophysiologic evidence. Pain. 68:141-150.
39. Zimmerman M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.